FDA Approves Likmez (metronidazole) Oral Suspension for the Treatment of Parasitic and Anaerobic Bacterial Infections

HALIFAX, Nova Scotia--(BUSINESS WIRE) September 25, 2023 -- Appili Therapeutics Inc. (TSX:APLI; OTCQB: APLIF) (the“Company” or“Appili”), a biopharmaceutical company focused on drug development for infectious diseases and...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news